1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
- 2017
- Genomic Amplifications and Distal 6q Loss are Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
- Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets
- 2016
- Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
- Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
- Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients
- 2015
- Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
- 2014
- Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups
- Emergence of new ALK mutations at relapse of neuroblastoma
- 2013
- Focal DNA copy number changes in neuroblastoma target MYCN regulated genes